Short interest in Biogen Inc. (NASDAQ:BIIB) fell 18.6% in December.
In December, there was a sizeable reduction in the number of short positions held in Biogen, Inc. As of December ...
Tag: BIIB, Analyst Rating
Biogen Inc. is owned by CIBC Asset Management Inc, which has a $9.75 million investment in the company (NASDAQ:BIIB)
The most recent Form 13F filing that CIBC Asset Management Inc. submitted to the Securities and Exchange Commission revealed that ...
FY2025 EPS Estimates for Biogen Inc. (NASDAQ:BIIB) Oppenheimer raised
NASDAQ: BIIB is the stock ticker for the American company Biogen Inc., which is in the biotechnology industry. In a ...
Update on Short Interest in Biogen Inc. (NASDAQ:BIIB)
In December, there was a sizeable reduction in the number of short positions held in Biogen Inc. (NASDAQ: BIIB). Since ...
Update on Short Interest in Biogen Inc. (NASDAQ:BIIB)
In December, there was a sizeable reduction in the number of short positions held in Biogen Inc. (NASDAQ: BIIB). Since ...
Biogen (NASDAQ:BIIB) sets a new 52-week high following an analyst upgrade.
Following the announcement that Jefferies Financial Group will be increasing their price objective from $325.00 to $350.00, shares of Biogen ...
The PT for Biogen (NASDAQ:BIIB) has been raised to $270.00.
According to Benzinga, in a research note distributed to investors on Friday, equity research analysts at Guggenheim lowered their price ...
PT Biogen (NASDAQ:BIIB) Increased to $270.00
According to Benzinga, Guggenheim analysts have increased their target price for Biogen (NASDAQ: BIIB) from $265.00 to $270.00 in a ...
The earnings guidance for the fiscal year 2022 has been released by Biogen (NASDAQ:BIIB).
Biogen (NASDAQ: BIIB), on Tuesday, February 5, provided updated profit guidance for the fiscal year 2022. In contrast to the ...
Biogen (NASDAQ:BIIB) Sets a New 1-Year High After Analyst Upgrade
On Tuesday, Biogen Inc. (NASDAQ: BIIB) stock hit a new 52-week high after Mizuho raised its price target from $270.00 ...
